To our knowledge, this is the first study to report the spectrum of germline pathogenic variants in genes beyond BRCA1/2 identified in breast cancer patients from Pakistan, using an NGS based multi-cancer gene panel and correlating with clinical characteristics. This evidence concerns the gene BRCA1 and cancer.